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Sodium orthovanadate caused a 2-fold stimulation of 
system A transport activity in soleus muscle, as as- 
sessed by the  uptake of the nonmetabolizable analog 2- 
(methy1amino)isobutyric acid (MeAIB). The effect of 
vanadate on system A was rapid, concentration-de- 
pendent and  was  characterized by an increased V,,, 
without modification of K ,  for MeAIB. Under  these 
conditions, vanadate also activated 3-0-methylglucose 
uptake  and  lactate production. The  effects of vanadate 
on muscle metabolism showed a complex interaction 
with  the ffects of insulin. Thus, the stimulatory  effects 
of vanadate  and insulin on  MeAIB and 3-0-methylglu- 
cose uptake  were not additive; however, the  effects of 
insulin  and  vanadate on lactate production were addi- 
tive. In spite of the lack of additivity, insulin- and 
vanadate-induced  stimulation of system A differed  in 
their sensitivity  to  gramicidin D, being the  vanadate 
effect more susceptible to  inhibition by gramicidin D 
than  the insulin effect. 
System A transport activity shows a dependence on 
pH, and  recent  results suggest the presence of critical 
histidine  residues on the A carrier  that may be respon- 
sible  for its pH dependence (Bertran, J., Roca, A., Pola, 
E., Testar, X., Zorzano, A. & Palacin, M. (1991) J. 
Biol. Chem. 266, 798-802). In  this  regard, a rise  in 
extracellular pH led to a substantial  activation of sys- 
tem A. Furthermore,  lowering of muscle intracellular 
pH induced by ethylisopropylamiloride (EIPA), a spe- 
cific inhibitor of sodium/proton exchange  activity, led 
to inhibition of system A. This suggests that  critical 
histidine residues are present in an  intracellular local- 
ization on the A carrier.  Furthermore,  the rate of mus- 
cle glycolysis was also altered in response to a rise in 
extracellular pH or to EIPA treatment. 
Regarding  the mechanisms involved in  vanadate  ac- 
tion, vanadate  treatment  in  the incubated soleus muscle 
did not cause any  significant  stimulation of tyrosine 
kinase  activity after  partial purification of muscle in- 
sulin receptors. On the  other hand, vanadate  but not 
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insulin caused a  substantial  increase in muscle intra- 
cellular pH as assessed by 5,6’-dimethyloxazolidine- 
2,4-dione equilibrium. This effect of vanadate on in- 
tracellular pH was not due to activation of the sodium/ 
proton  exchanger,  since  it  was not blocked by EIPA. 
Based on these findings, we suggest that alkalinization 
of muscle intracellular pH might mediate the effects of 
vanadate on system A and on  glycolysis. 
The system A carrier is a plasma membrane-bound activity 
which translocates short polar, straight chain amino acids, 
including the nonmetabolizable analog 2-(methylamino) 
isobutyric acid. Transport by system A is sodium-dependent 
and  its activity is greatly reduced at lowered extracellular pH, 
as assessed in isolated cells or in plasma membrane vesicles 
(1-4). In  this connection, system A transport activity is sen- 
sitive to histidine-modifying reagents such as diethyl pyrocar- 
bonate ( 5 ) .  Furthermore, diethyl pyrocarbonate-mediated sys- 
tem A carrier modification shows a clear pH dependence, 
suggesting that  the modified residue/s are involved in the  pH 
dependence of system A carrier activity ( 5 ) .  
System A transport activity is subjected to hormonal regu- 
lation,  transinhibition,  and adaptive regulation in a variety of 
cell types (6-8). In skeletal muscle, system A transport activ- 
ity is stimulated in response to amino acid starvation, i.e. 
adaptive regulation (9, lo), by a mechanism that requires 
protein  synthesis  and  unaltered microtubular function (11). 
On the other hand, system A transport activity is rapidly 
activated  in skeletal muscle by insulin (12) or acute exercise 
(13). In skeletal muscle, the effect of insulin on system A 
transport activity is characterized by its independence of 
protein  synthesis (14, E), microtubular function (ll), and the 
sodium electrochemical gradient (14, 16). 
Vanadate is an agent which mimics many of the insulin 
effects in insulin-sensitive tissues (17). In connection with 
muscle, vanadate has been reported to stimulate the rates of 
hexose uptake, glycogen synthesis and glycolysis (18, 19), 
processes that  are also activated in response to insulin. How- 
ever, not  all insulin effects are mimicked in skeletal muscle 
in response to vanadate,  as for muscle protein  synthesis  and 
protein degradation (18). In addition, chronic administration 
of vanadate to  rats augments muscle insulin sensitivity (20) 
and, under some conditions, chronic vanadate normalizes 
muscle  glycogen  levels and glycogen synthase activity in dia- 
betic rats (21). The mechanisms by which vanadate exerts 
these acute and chronic effects in skeletal muscle are un- 
known; however, based on observations in mouse diaphragm 
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"in vivo," vanadate actions do not seem to be related to 
activation of insulin  receptor  kinase (22). 
In this communication  we demonstrate that vanadate  and 
modification of intracellular pH markedly alters system A 
transport activity as well as glycolysis  in  skeletal  muscle. In 
addition, we  show that vanadate  does  not  stimulate  tyrosine 
kinase activity of insulin receptors, but it increases muscle 
intracellular pH. Our data indicate that raising of muscle 
intracellular pH might mediate the effects of vanadate on 
system A and on glycolytic  rate. 
EXPERIMENTAL PROCEDURES 
Materials-Porcine monocomponent insulin was a gift from T. L. 
Jeatran, Eli Lilly & Co. Ethylisopropylamiloride (EIPA)' was kindly 
donated by Dr. Jurg Biber (University of Zurich). ['251-Ty#'4]Mon- 
oiodoinsulin, [1-"C]2-(methy1amino)isobutyric acid, [3H]mannitol, 
["C]-3-O-methylglucose, and [l-14C]5,5'-dimethyloxazolidine-2,4- 
dione (DMO) were obtained from Du Pont-New England Nuclear. 
[y3'P]ATP was prepared from [32P]orthophosphate (Du Pont-New 
England Nuclear) using a Gamma-prep kit from Promega Biotech. 
Wheat germ agglutinin (WGA) bound to agarose was obtained from 
Vector. Bovine serum albumin (fraction  V albumin, fatty acid free), 
sodium orthovanadate, gramicidin D, copolymer of Glu/Tyr (4:1), 
and most commonly used chemicals were from Sigma. 
Animals and Dissection Procedures-Male Wistar rats (60-70 g), 
obtained from our own  colony  were  used. The  rats were fed on Purina 
Laboratory chow ad libitum. Animals were housed in animal  quarters 
maintained at 22  "C with a  12-h light/l2-h dark cycle. The dissection 
and isolation of the soleus muscle  was carried out under anesthesia 
with pentobarbital (5-7  mg/100 g body weight, intraperitoneally) as 
described previously (23). The isolated soleus muscle  was fixed to a 
stainless-steel clip in order to maintain the muscle under slight 
tension (approximating the resting length) during the incubation. 
Such muscles (20-30 mg weight) are able to maintain normal ATP 
and creatine  phosphate  concentrations during a 3-h incubation. 
Incubations-Soleus muscles were incubated in  a  shaking incubator 
a t  37 "C for 3  h in 3 ml  of Krebs-Henseleit buffer, pH 7.4, containing 
5 mM glucose,  0.10% bovine serum albumin, and 20 mM Hepes. After 
addition of the muscles to  the vials, they were stoppered and placed 
in a Dubnoff metabolic shaker set a t  37 "C and a  shaking rate of 60 
cycles/min. Vials  were gassed with 95% 0, and 5% CO, throughout 
the incubation period. The incubation medium was kept for no longer 
than 90 min, and during prolonged incubations it was renewed every 
90 min. At different times, sodium orthovanadate and insulin as well 
as several drugs such as gramicidin D or EIPA were added to  the 
incubation medium (see details  in figure legends). Experimental series 
were performed by comparing biological activity of one muscle to  the 
contralateral one from the same rat (paired muscles). 
Measurement of Amino  Acid and Glucose Uptake and Lactate Pro- 
duction by Muscle-Amino acid uptake by system A was measured in 
soleus muscles using the nonmetabolizable amino acid analog 2- 
(methy1amino)isobutyric acid (MeAIB). Following incubation with 
sodium orthovanadate and  the above-mentioned agents, muscles were 
transferred to vials with 1.5 ml of Krebs-Henseleit buffer, pH 7.4, 
containing 5 mM glucose, 0.10% bovine serum albumin, 20 mM Hepes, 
and 0.1 mM [l-'4C]2-(methylamino)isobutyric acid (800 pCi/mmol), 
1 mM [3H]mannitol (330 pCi/mmol), and  the different modulators a t  
the same concentrations as for the preceding incubation period. The 
vials were stoppered and incubated at 37 "C in  a  shaking incubator 
for 30 min. The uptake of MeAIB is  linear with time for at least 30 
min (11, 14). The gas phase in the vials was 95% 0, and 5% CO,. In 
experiments designed to measure 3-0-methylglucose uptake, muscles 
were incubated in Krebs-Henseleit buffer containing  2 mM pyruvate 
instead of glucose, and for the  last 30 min of incubation, the medium 
contained 0.1 mM [14C]3-O-methylglucose (800 pCi/mmol) and 1 mM 
[3H]mannitol (330 pCi/mmol). Following incubation, muscles were 
rapidly washed in saline and frozen in liquid nitrogen. Muscles were 
then digested in 0.25 ml of 0.5 M Protosol tissue solubilizer (Du Pont), 
and radioactivity of muscle digests and aliquots of the incubation 
media was counted. The amount of each isotope present in the 
The abbreviations used are: EIPA, ethylisopropylamiloride; 
DMO, 5,5'-dimethyloxazolidine-2,4-dione; WGA, wheat germ agglu- 
tinin; Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; 
MeAIB, 2-(methy1amino)isobutyric acid. 
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samples was determined, and  this information was used to calculate 
the extracellular space. The extracellular space of soleus muscles, 
estimated after 30 min of [3H]mannitol addition, was 0.314 f 0.002 
ml/g and was not modified by treatment with vanadate,  EIPA, high 
extracellular pH, or gramicidin D (data not shown). Intracellular 
concentration of "C-amino acid analog or ['4C]3-O-methylglucose 
was calculated by subtracting its amount  in the extracellular space 
from the  total label found in tissue, as previously reported (24). It 
should be mentioned that more than 85% of total MeAIB uptake by 
soleus muscle  was attributable to activity of a Na+-dependent trans- 
port system (system A), in keeping with previous observations in the 
incubated epitrochlearis muscle (25). Thus, whereas total MeAIB 
uptake (in the presence of sodium) was 35.8 k 2.1 nmol/g per 30 
min, MeAIB uptake  in the presence of choline chloride (sodium-free 
medium) was 5.5 k 0.1 nmol/g per 30 min. Lactate release to  the 
incubation media  was measured for the last 30 min of incubation as 
in Ref. 26. Student's  t tests for paired and unpaired data were used 
for statistical analysis. 
Determination of ZntracellularpH-Intracellular pH was measured 
in incubated soleus muscle in the absence or presence of vanadate, 
insulin, gramicidin D, or EIPA by using DM0 (27). Following an 
initial incubation period for 90 min, muscles were transferred to vials 
with 3 ml of Krebs-Henseleit buffer, pH 7.4, containing 5 mM glucose, 
0.10% bovine serum albumin, 20 mM Hepes, 1 mM [l-"C]DMO (800 
pCi/mmol), 1 mM [3H]mannitol (330 pCi/mmol), and  the different 
modulators at  the same concentrations as for the preceding incuba- 
tion period. The vials were stoppered and incubated at 37 "C in  a 
shaking incubator for 90 min. Following incubation, muscles were 
digested in Protosol tissue solubilizer, and radioactivity of muscle 
digests and aliquots of the incubation media was counted. Extracel- 
lular space was calculated, and hence the distribution  ratio [DMO]i/ 
[DMO],  was obtained. Intracellular pH (pHi) was calculated from the 
following equation (27). 
pK. was taken to be  6.13 (27). 
Preparation of Insulin Receptors-Soleus muscles were incubated 
for 3  h  in  3 ml of Krebs-Henseleit buffer, pH 7.4, containing 5 mM 
glucose, 0.10% bovine serum albumin, and 20 mM Hepes. For the  last 
90 min, muscles were incubated in the absence or presence of 8 mM 
orthovanadate. At the end of the incubation period, muscles were 
frozen in liquid nitrogen. Pools from 10-15 muscles (approximately 
250-300  mg  of tissue) were  homogenized and solubilized in 1% Triton 
X-100 as described (28) in the presence of inhibitors of proteases and 
phosphatases. The solubilized homogenate was centrifuged at 150,000 
X g for 90 min at 4 'C. The 150,000 X g supernatant (1.8 ml) was 
recycled for 30 min (approximately five to seven times) through a 
column containing 0.2 ml of WGA bound to agarose at 4 "C. The 
resin was washed with buffer (20 ml) containing 25 mM Hepes, 0.1% 
Triton X-100, pH 7.4. Receptors were eluted from the WGA column 
with 2 ml of buffer containing 25 mM Hepes, 0.1% Triton X-100 and 
0.3 M N-acetyl-D-glucosamine, pH 7.4. Insulin receptors were eluted 
in the first 400 p1  of elution buffer. Insulin binding was measured by 
incubating 20 pl of  WGA eluate in 30 mM Hepes buffer containing 
0.1% bovine serum albumin, 100 units/ml bacitracin (pH 7.6, 1 h, 
22 "C, 200 p l )  and 20,000 cpm ['251-Ty#'4]m~n~iodoinsulin (-60 pM) 
(40). Nonspecific binding was estimated as '=I-insulin bound in the 
presence of 1 p~ insulin (5-10% of total binding). Binding data were 
the method of Bradford (29). 
expressed per microgram of protein with the  latter measured using 
Assay of Tyrosine Receptor Kinase Activity-Phosphorylation of 
an exogenous substrate was carried out with receptor preparations 
which were preincubated for 1 h in 30 mM Hepes buffer, pH 7.6, 
containing 50 mM Mg acetate,  4 mM MnCl,, and varying concentra- 
tions of insulin. The receptor kinase activity was initially activated 
by the addition of 50 p M  [Y-~~P]ATP (5-10 pCi) for 10 min. The 
reaction was initiated by the addition of the exogenous substrate 
(copolymer of Glu/Tyr, 4:1,  0.25 mg/ml). The reaction was stopped 
3  MM), which were immediately washed in 10% trichloroacetic acid 
after 30 min by applying samples to filter paper squares (Whatmann 
containing 10 mM sodium pyrophosphate. Papers were washed, dried, 
and counted as described (30). 
RESULTS 
Vanadate Stimulates System A and Glucose Metabolism in 
Skeletal Muscle-The effect of  sodium  orthovanadate on sys- 
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tem A amino acid transport activity was assessed in the 
incubated soleus muscle preparation. We traced, in parallel, 
a previously reported effect of vanadate, i.e. its  stimulatory 
action on muscle lactate production (18). Vanadate (8 mM) 
caused a  near 2-fold increase in the  rate of lactate production 
in soleus muscle, which was already maximal at 30 min after 
vanadate  addition (Fig. lA). Vanadate also stimulated system 
A  transport activity as  determined by the uptake of MeAIB 
(80% increase) (Fig. lA). This effect of vanadate was time- 
dependent so the time  taken for 50% effectiveness of vanadate 
action was approximately 30 min, and maximal effect of 
vanadate was found at 1 h (Fig. lA). 
These effects of vanadate were dependent upon its concen- 
tration in the incubation medium (Fig. 1B).  Thus,  the half- 
maximal effect of vanadate  on muscle lactate production was 
already obtained at approximately 0.5 mM (Fig. 1B). In con- 
trast,  the dose-response curve of vanadate on MeAIB uptake 
was clearly shifted to  the right, and two components were 
apparent.  Thus, low vanadate  concentrations  (up to 1-2  mM) 
caused a 25% stimulation of MeAIB uptake (Fig. 1B). At 
higher vanadate  concentrations, the stimulation  exerted on 
MeAIB uptake was characterized by a markedly gentler slope, 
and a  plateau phase was not reached even at 12 mM vanadate 
(Fig. 1B). 
Kinetic analysis of the stimulatory effect of vanadate on 
MeAIB uptake (Fig. 2) indicated that  it was characterized by 
an  increased Vmax (291.7 k 24.1 and 511.8 & 38.2 nmol of 
MeAIB/g per 30 min in  the absence and in the presence of 
vanadate, respectively), without modifications of K ,  for 
MeAIB (0.85 k 0.14 and 0.92 f 0.09 mM in  the absence and 
A )  
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FIG. 1. Time course  and concentration dependence of van- 
adate-induced activation of MeAIB uptake and lactate pro- 
duction by soleus muscle. Results are means f S.E. for five to 11 
observations per group. MeAIB uptake (B) and lactate production 
(0) were determined during the last 30 min of incubation. Basal 
MeAIB uptake and lactate production were 35.8 f 1.7 nmol/g per 30 
min and 10.9 & 0.7 pmol/g per  h, respectively. A, soleus muscles were 
incubated for 180 min in the absence or in the presence of 8 mM 
vanadate added during the last 30, 60, or 90 min of the incubation 
time. When vanadate was present during the last 30 min, refers to 
vanadate added only during the MeAIB uptake period, whereas 
vanadate for 60 or 90 min refers to vanadate added 30 or 60 min 
before the MeAIB uptake period. B, soleus muscles were incubated 
for 180 min with different concentrations of vanadate  (ranging 0-12 
mM) added during the last 90 min of the incubation period. 
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FIG. 2. Effect of vanadate on  the kinetic analysis of MeAIB 
uptake by soleus muscle. Muscles were incubated as described 
under “Experimental Procedures” for 180 min, in the absence or 
presence of 8 mM vanadate for the last 90 min of the incubation 
period. Results are mean f S.E. of four observations per group. 
Uptake was measured at different concentrations of MeAIB (mM) for 
30 min ( A ) .  A Lineweaver-Burk plot is presented in B. Statistical 
analysis of double-inverse representation demonstrated that linear 
regression was significantly different in control ( r  = 0.969; y = 0.00350 
+ 0.00347~)  as compared with vanadate-treated group ( r  = 0.998; y 
= 0.00148 + 0.00206~) at p < 0.05. 
in  the presence of vanadate, respectively). 
In order to provide a  first insight into  the mechanisms by 
which vanadate  stimulates skeletal muscle activity, we inves- 
tigated the interaction of insulin and vanadate on MeAIB 
uptake,  lactate production, and glucose transport. Incubation 
in  the presence of vanadate (8 mM, 90 min) or with insulin 
(100 nM, 60 min)  stimulated MeAIB uptake by soleus muscle 
to  the same extent (Fig. 3A). However, the combined effects 
of insulin and  vanadate did not cause any  additional signifi- 
cant stimulatory effect on MeAIB uptake (Fig. 3A). The 
interaction between insulin and  vanadate  on  3-0-methylglu- 
cose uptake followed the same pattern as MeAIB uptake. 
Thus, either agent acting separately stimulated uptake to 
approximately the same extent, but no additive effects were 
detected (Fig. 3B). On the contrary, insulin and vanadate 
stimulated  lactate production in such a way that their effects 
were  fully additive (Fig. 3C). 
The complex interaction of insulin  and  vanadate on  biolog- 
ical effects in skeletal muscle suggested that  at least some 
effects of vanadate might be a consequence of the triggering 
of events  other than those involved in insulin action. There- 
fore, we attempted to investigate whether it was  possible to 
differentiate the effects of vanadate  and insulin on MeAIB 
uptake. To  that end, we investigated the effect of gramicidin 
D, an ionophore known to abolish membrane potential (31). 
In keeping with its effects on membrane potential, exposure 
for only the last 30 min of incubation to gramicidin D caused 
a 29-33% reduction in basal and  insulin-stimulated MeAIB 
uptake by muscle (Table I), in agreement with previous ob- 
servations performed in  the incubated rat extensor digitorum 
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FIG. 3. Interaction of vanadate  and  insulin on MeAIB and 
3-0-methylglucose uptake and lactate production in soleus 
muscle. Results are means f S.E. for 5 to 12 observations per group. 
Soleus muscles  were incubated for 180 min in the absence or presence 
of insulin (100 nM, last 60 min of incubation period) or  vanadate (8 
mM, last 90 min of incubation period). MeAIB uptake and lactate 
production were determined during the last 30 min of incubation. 
Under all conditions, insulin and vanadate significantly stimulated 
MeAIB uptake, 3-0-methylglucose uptake, and lactate production at 
p < 0.05. *, a significant difference between vanadate + insulin (V + 
I )  group compared to  the vanadate ( V )  group or insulin ( I )  group ( p  
< 0.05) (unpaired t test). 
TABLE I
Effect of gramicidin D on  vanadate- and insulin-stimuhted  MeAIB 
uptake by soleus muscle 
Results are means f S.E. for four to six observations per group. 
Soleus muscles were incubated for 180 min. When indicated, insulin 
(100 nM)  was present for the last 60 min of incubation, vanadate (8 
mM) for the last 90 min of incubation, and gramicidin D (25 pg/ml) 
was added for the last 30 min of the experiment. Gramicidin D was 
dissolved in 60% ethanol, so the final ethanol  concentration  in the 
tained 1% ethanol  in the medium. 
incubation medium  was 1%; therefore, the control groups also con- 
Basal Vanadate Basal Insulin 
~ ~~ ~ 
nmol MeAIB.gl .30 rnin" 
Control 30.6 f 3.0 60.2 f 3.5" 36.6 f 2.6 65.9 f 6.6" 
Gramicidin D 21.8 f 2.0b 28.3 f 2.2"~~ 22.9 f 1.5b 43.9 k 5.3OSb 
Value significantly different from that of the basal (no insulin or 
Indicates a significant difference between control and gramicidin 
vanadate) group (p < 0.05) (paired t test). 
D-treated groups, a t  p < 0.05 (unpaired t test). 
longus muscle (14). However, gramicidin D caused a 53% 
reduction in the vanadate-stimulated MeAIB uptake  (Table 
I). Thus,  the  vanadate effect is more susceptible to inhibition 
by gramicidin D than  the insulin-stimulated or basal transport 
activity of system A. 
Effect of Vanadate on Muscle Insulin Receptor-To  provide 
information on the mechanisms by which vanadate  stimulates 
skeletal muscle metabolism, we investigated whether exposure 
to vanadate caused stimulation of the tyrosine kinase activity 
of insulin receptors. Prior  reports on this issue are controver- 
sial, and whereas some authors indicated a vanadate-induced 
activation of the receptor kinase activity (32-34), others did 
not find any  stimulation (22, 35). To this end, insulin recep- 
tors from control  and 90-min vanadate-treated soleus muscles 
were partially purified by  WGA affinity chromatography. No 
difference in  the yield of glycoproteins was detected between 
the two groups (0.40 f 0.02 and 0.39 f 0.16 pg/mg of muscle 
in control and vanadate-treated muscles, respectively, ob- 
tained in four separate experiments). However, treatment 
with vanadate led to a decrease in insulin binding compared 
to control receptors (the means f S.E. of three separate 
experiments were 0.15 f 0.002 and 0.11 f 0.005 fmollpg of 
protein eluted from the column in control and vanadate- 
treated muscles, respectively, being the differences statisti- 
cally significant at p < 0.05). 
The kinase activity of the insulin receptor in control and 
vanadate-treated soleus muscle  was characterized by using an 
exogenous substrate. The dose/response relationship between 
insulin and 32P incorporation into  a copolymer of Glu/Tyr, in 
the presence of purified insulin receptor, is presented in Fig. 
4. Insulin stimulated the exogenous kinase activity of the 
insulin receptor from control muscle as previously shown (28, 
30). Thus, 1 nM insulin caused an approximately half-maxi- 
mal stimulation of the rate of exogenous substrate phos- 
phorylation, and at 10 nM insulin stimulation was almost 
maximal (Fig. 4). Supramaximal insulin caused a 2-fold in- 
crease in exogenous kinase activity from control insulin recep- 
tors. Insulin receptors partially purified from vanadate- 
treated muscles exhibited a similar ability to phosphorylate 
O +  
0 ,1 1 10 loo  
Insulin (nM) 
FIG. 4. Effect of vanadate on exogenous kinase  activity of 
insulin  receptors from muscle. Insulin receptors from soleus mus- 
cles treated (0) or not (B) with 8 mM vanadate for 90 min were 
partially purified as described under "Experimental Procedures." 
Each  preparation was obtained by pooling muscles from 10-12 rats. 
WGA eluates (10 pl) were incubated at 22 "C for 1 h  in 30 mM Hepes 
buffer, pH 7.6, containing 50 mM magnesium acetate, 4 mM man- 
ganese chloride, and various concentrations of insulin. [Y-~'P]ATP 
(50 p ~ )  was added and samples were incubated for an additional 10 
min. The substrate (copolymer of Glu/Tyr, 4:l; 0.25 mg/ml) was then 
added and allowed to react for 30 min. The reaction was stopped by 
applying samples to filter paper squares and soaking in 10% trichlo- 
roacetic acid/lO mM sodium pyrophosphate. Papers were washed, 
dried, and counted by Cerenkov radiation. All values have been 
corrected by nonspecific association of 32P with the paper, which  was 
estimated by incubating samples in the absence of receptor addition. 
Each data point is the mean of triplicate estimations, and  the results 
shown are representative of four different experiments with inde- 
pendent receptor preparations. Standard errors ranged between 3 and 
7% of mean values. 
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the exogenous substrate in the absence as well as in the 
presence of insulin as compared with the control group, when 
data were expressed per fmol of insulin binding (Fig. 4). 
Effect of Modification of Muscle Intracellular pH on System 
A Transport  Activity and h t a t e  Production-Previous ob- 
servations performed on isolated cells or plasma membrane 
vesicles have substantiated that system A transport activity 
is pH-sensitive, so a rise from pH 7.0 to 7.6 leads to an 
increase in its activity (1-4). In this regard, this effect is 
somewhat analogous to  that displayed by phosphofructoki- 
nase  1, an enzyme which plays a regulatory role in glycolysis, 
and which can be activated by an increase in pH (36). Fur- 
thermore, we have recently reported the presence of critical 
histidine residues in  the hepatic A  carrier that may be respon- 
sible for its  pH dependence (5). In  an initial  set of experi- 
ments, we investigated the effect of increasing the  pH of the 
extracellular medium on MeAIB uptake by soleus muscle. 
Previous observations, in  the incubated mouse soleus muscle, 
indicate that intracellular pH increases approximately 0.38 
for  a  1-unit increase in extracellular pH (37). The increase in 
the pH of the extracellular medium from 7.4 to 8.6 caused a 
76% increase in MeAIB uptake by  muscle (Table IIA). Further 
increase to 8.9 in the  pH of the extracellular medium caused 
an  additional stimulation of muscle MeAIB uptake (Table 
IIA). Similarly, a  substantial  stimulation in the  rate of muscle 
lactate production was detected in response to  an increase in 
the extracellular pH (Table  IIB). The effect of vanadate  and 
extracellular pH on MeAIB uptake or lactate production were 
never additive (Table 11). 
To explore whether modifications of pH restricted to  the 
intracellular  compartment might be sufficient to alter system 
A transport, we investigated the effect of EIPA, a specific 
blocker of the sodium/proton exchange (38), on intracellular 
pH, lactate production, and MeAIB uptake by the incubated 
soleus muscle. To determine  intracellular  pH, we used labeled 
DM0 as  a probe, which provides good estimations of muscle 
pH, when extracellular pH is neutral (pH, of  7.4) (27). In  the 
basal  state,  intracellular muscle pH ranged between 7.04 and 
7.11 (Tables I11 and IV),  in agreement with previous obser- 
TABLE I1 
Effect of extracellular pH and  vanadate  on MeAZB uptake and lactate 
production by soleus muscle 
with the exception of MeAIB uptake data corresponding to  pH 8.9 
Results are means f S.E. for three  to six observations per group 
under control conditions which  were performed in duplicate (individ- 
ual values are shown in  parenthesis). Soleus muscles were incubated 
for 180 min in incubation media at  different pH  and in the absence 
or presence of vanadate (8 mM, last 90 min of incubation). MeAIB 
uptake  and lactate production were determined during the  last 30 
min of incubation. 
A. MeAIB  uptake 
PH, Basal Vanadate 
nmol MeAIB.g-l.30 min" 
7.4  33.3 f 2.7  64.1 f 4.7b 
8.6 
8.9 
58.7 f 1.3" 
86.8  (84.7,  8.8) 62.5 f 4.8 
B. Lactate production 
Basal Vanadate 
pmol k7ctate.g". h" 
7.4  10.1 & 0.6 
8.6 
8.9 
15.8 f 1.7" 
23.8 & 1.9"  23.7 f 1.1 
20.8 & 1.4' 
Value significantly different from that of the  pH 7.4 group (p < 
Value significantly different from that of the basal (no vanadate) 
0.05) (unpaired t test). 
group ( p  C 0.05) (paired t test). 
TABLE I11 
Effect of EZPA treatment  on intracellular pH, MeAZB uptake, and 
lactate production by soleus muscle 
Results are  means f S.E. for five to six observations per group. 
Soleus muscles were incubated for 180 min in the absence or presence 
of EIPA (10 FM,  last 120 min of incubation period). Intracellular pH 
was determined by using [14C]DM0 as a probe. MeAlB uptake and 
lactate production were determined during the  last 30 min of incu- 
bation. 
Intracellular pH  MeAIB  uptake Lactate production 
nmol M4IB.g - l . 30  min" pmol lactate.g".h" 
Control 7.03 & 0.04 33.5 f 2.4 7.4 f 0.2 
EIPA 6.89 k 0.05" 21.5 f 2.5" 5.9 f 0.6" 
a Value significantly different from that of the control (no EIPA) 
group ( p  < 0.05) (paired t test). 
TABLE IV 
Effect of vanadate and insulin  on intracellular pH  in soleus muscle 
Results are means f S.E. for five to six observations per group. 
Soleus muscle  was incubated for 180 min in the absence or presence 
of insulin (100 nM, 60 min)  or  vanadate (8 mM, 90 min). Intracellular 
pH was determined by using [14C]DM0 as a probe. 
Intracellular pH 
Basal 7.03 f 0.03 
Insulin 7.04 f 0.01 
Basal 7.11 f 0.02 
Vanadate 7.22 f 0.05" 
"Value significantly different from that of the basal group (p < 
0.05) (paired t test). 
vations using DM0 equilibration, 'H NMR, or application of 
enzyme equilibria (39-41). As expected, treatment of soleus 
muscle with 10 p~ EIPA caused a substantial decrease in 
intracellular muscle pH (0.14-unit decrease, equivalent to a 
38% increase in intracellular [H'J) (Table 111). Furthermore, 
EIPA reduced muscle  MeAIB uptake by  36% (Table 111). This 
effect of EIPA on MeAIB uptake was not consequence of a 
direct effect of EIPA on system A transport activity and, in 
fact,  concentrations of EIPA  as high as 20 p~ did not  alter 
system A in plasma membrane vesicles isolated from rat liver 
after incubation for 10 min at room temperature (data not 
shown). Incubation of rat liver plasma membrane vesicles for 
10 min in  the presence of  20 p~ EIPA was enough to detect 
an almost total inhibition of system ASC transport activity 
(data not shown). EIPA also caused a significant decrease 
(21%) in lactate production by soleus muscle (Table 111). In 
keeping with the view that changes in  the intracellular  pH 
lead to alterations in the activity of system A,  we found that 
gramicidin D (25 pg/ml, 30 min), an ionophore that markedly 
reduces system A in muscle (Table I), caused a large decrease 
in muscle intracellular pH (7.04 f 0.01 and 6.93 f 0.02 in 
control  and gramicidin D-treated muscles, respectively, being 
the differences statistically significant at p < 0.05). Therefore, 
at least part of the inhibitory effect of gramicidin D on system 
A might be due to  its action on intracellular  pH. 
Effect of Vanadate and Insulin on  Muscle  IntracellularpH- 
Vanadate  has been shown to cause modifications of intracel- 
lular pH in A431 cells (42). Based on that, we next searched 
for a possible effect of vanadate on intracellular muscle pH. 
In  the basal state,  intracellular muscle pH ranged between 
7.04 and 7.11 (Table IV). Under these conditions, supramax- 
imal concentrations of insulin did not cause any modification 
of intracellular  pH  (Table IV). In  contrast,  treatment for 90 
min with 8 mM vanadate caused a marked and significant 
increase in muscle intracellular  pH (0.11-unit increase) (Table 
IV). Next, we studied whether the effects of vanadate were 
due to activation of the sodium/proton exchanger. To this 
end, the activity of the sodium/proton exchange was inhibited 
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with EIPA. Under basal state,  the presence of 10 PM EIPA 
for 120 min caused a  substantial decrease (0.12-unit decrease) 
in muscle intracellular pH (Table V). However, EIPA did not 
block the effect of vanadate on muscle intracellular  pH, so 
whereas in the absence of EIPA, vanadate increased pH by 
0.11 units, in the presence of EIPA the vanadate-induced 
increase in pH was of  0.17 (Table V). In conclusion, vanadate 
causes alkalinization of muscle pH by a mechanism other 
than sodium/proton exchange activation. Furthermore, we 
found that incubation of muscles in  the presence of EIPA did 
not prevent the effect of vanadate on MeAIB uptake (Fig. 
5A)  and  lactate production (Fig. 5B) .  Under these conditions 
TABLE V 
Effect of EIPA on vanadate-induced pH increase in soleus  muscle 
Results are means f S.E. for four observations per group. Soleus 
muscles were incubated for 180 min in the absence or presence of 
vanadate (8 mM, 90 min) and EIPA (10 pM, 120 rnin). Intracellular 




Control 7.08 +. 0.03  7.19 +. 0.01" 
6.96 k 0.03'  7.13 f 0.03".b 
Value significantly 
0.05) (paired t test). 
Value significantly 
0.05) (unpaired  t test). 
different from that of the basal group (p < 
different from that of the EIPA group ( p  < 
0 I 
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FIG. 5. Relationship between MeAIB uptake  or lactate pro- 
duction and intracellular pH in soleus muscle. Points are means 
+- S.E. for four to seven observations. Soleus muscles were incubated 
for 180 min in the absence or presence of insulin (100 nM, last 60 
min of incubation period), vanadate (8 mM, last 90 min of incubation 
period), or EIPA (10 p ~ ,  last 120 min of the incubation period). 
MeAIB uptake (A) and lactate production ( B )  were determined 
during the last 30 min of incubation. W, no EIPA; 0, EIPA. Data 
from basal (with and without EIPA) and from vanadate-treated 
muscles (with and without EIPA) fitted very well to exponential 
functions. For MeAIB uptake  data, the statistical  parameters of the 
exponential curve was r = 0.975 and y = 2.1920. 10'2.w49*'. For 
lactate production data, the statistical  parameters of the exponential 
curve was r = 0.936 and y = 2.0086. 10'1.9362"' 
groups treated with or without EIPA were arbitrarily drawn to differ- 
. Lines connecting 
entiate basal, insulin-, and vanadate-treated muscles. 
and  as expected, insulin effects on  MeAIB uptake  and  lactate 
production by soleus muscle  were not blocked in the presence 
of EIPA (Fig. 5). 
DISCUSSION 
Our study  demonstrates that vanadate  stimulates system A 
transport activity in skeletal muscle. This finding indicates 
that in skeletal muscle, vanadate action is not limited to 
glucose metabolism through  activation of glucose transport, 
glycogen synthesis,  and glycolysis  (18-20), but it also 
enhances  amino acid uptake. The stimulatory effect of vana- 
date on system A is rapid (time for 50% effectiveness of 30 
min), dependent on vanadate  concentration  and characterized 
by enhanced V,,, values, suggesting a  stimulatory effect of 
vanadate on the activity of the A carriers. 
Vanadate is known to inhibit the activity of P-type AT- 
Pases in  vitro (43),  but  not in uivo (44), probably due to  the 
fact that the internalized vanadate is rapidly reduced to 
vanadyl iones (44-46), which does not inhibit the Na+-K+- 
ATPase  (45). In addition, the actual  inhibition of the Na+- 
K+-ATPase markedly inhibits  a-aminoisobutyric acid uptake 
by the perfused rat hindquarter (16) and MeAIB uptake by 
the incubated muscle (14). Therefore, vanadate-induced ac- 
tivation of system A found in muscle is unrelated to inhibition 
of Na+-K+-ATPase activity. 
Previous observations have reported that system A trans- 
port activity shows a clear pH dependence, concluded after 
exposure of isolated cells or membrane vesicles to increasing 
extracellular pH (1-4). In  this regard, we have demonstrated 
that a rise in the extracellular pH increases MeAIB uptake 
by the incubated muscle. Furthermore, we have also observed 
that EIPA-induced acidification of muscle intracellular pH 
(0.14-unit decrease or a 28% increase in  intracellular  [H+]) 
inhibits system A transport activity in  a  substantial manner. 
We  have recently reported the presence of critical histidine 
residues in  the system A carrier that might be responsible for 
the  pH dependence of system A transport activity (5). Based 
upon all these findings, we suggest that histidine residues 
present  a cytosolic localization in  the A carrier. 
Vanadate is a  potent  inhibitor of phosphotyrosine phospha- 
tases  (47,48),  and under some conditions it has been reported 
to stimulate insulin receptor kinase activity (32-34), although 
this is not  a generalized finding (22, 35). In  this report, we 
have failed to detect vanadate-induced modifications of tyro- 
sine receptor kinase. This agrees with the finding that vana- 
date does not mimic all insulin effects in skeletal muscle: for 
instance it does not modify rates of muscle protein synthesis 
or protein degradation (18). It also agrees with observations 
performed in isolated rat adiopocytes indicating that vanadate 
action is mediated at a postinsulin-receptor level (49). We 
have found that vanadate raises muscle intracellular pH (0.1- 
unit increase), and we propose that this effect could be a 
triggering element for some vanadate  actions in skeletal mus- 
cle. This is based on the following findings: (a) a decrease in 
muscle intracellular  pH obtained after  treatment with EIPA 
inhibits  both  lactate production and MeAIB uptake, ( b )  the 
alkalinization of the extracellular medium causes an enhance- 
ment of lactate production and system A transport activity, 
( c )  there is no additive effects between vanadate  and increas- 
ing extracellular pH on lactate production or MeAIB uptake, 
and ( d )  within the range of intracellular  pH from  6.96 to 7.19, 
there is a correlation between pH  and system A activity or 
lactate production (Fig. 5). 
It has previously been reported that vanadate raises intra- 
cellular pH in A431 cells by a mechanism dependent on the 
activity of the Na+/H+ exchanger (42). However, we have 
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found that EIPA does not block vanadate-induced  alkalini- 
zation in skeletal muscle and, in addition, it does not  inhibit 
the effect of vanadate  on MeAIB uptake  or  lactate production. 
Therefore, we conclude that whatever the mechanisms trig- 
gered by vanadate, the  Na+/H+ exchange activity is not  in- 
volved. 
Acute exercise and electrical stimulation rapidly stimulate 
system A transport activity in skeletal muscle (13, 16), and 
this might occur in the presence of acidification of intracel- 
lular pH (40, 41, 50). That indicates (a) that pH does not 
mediate the exercise-induced activation of system A, and ( b )  
that a variety of mechanisms may regulate the activity of the 
A carrier under in uiuo conditions. 
The previously reported effects of insulin on muscle intra- 
cellular pH  are contradictory. Thus, insulin has been reported 
to cause cytosolic alkalinization in frog sartorius muscle (39) 
and  in cultured L6H9 muscle cells (51). However, no effect 
has been substantiated in rat skeletal muscle (52) or  in avian 
skeletal muscle cells in  culture (53). In agreement with the 
latter view, we failed to detect  any modification of intracel- 
lular pH in rat soleus muscle, under conditions in which 
effects of vanadate  or  EIPA on intracellular pH were evident. 
This finding excludes pH  as a regulatory element involved in 
signal transduction of insulin action  in rat skeletal muscle. 
The results of our study  indicate that  the mechanisms by 
which insulin and vanadate stimulate system A transport 
activity are different. This is based on two experimental 
findings: (a) vanadate  but  not insulin raises muscle intracel- 
lular  pH,  and  this alkalinization stimulates system A trans- 
port activity, and ( b )  the effect of vanadate is more susceptible 
to inhibition by gramicidin D than  the insulin effect. We  have 
observed that,  at least, part of the inhibitory effect of grami- 
cidin D on system A might be due to acidification of muscle 
intracellular pH. In this regard, the greater sensitivity of 
vanadate to gramicidin D compared to insulin, might be 
explained by the curvilinear relationship found between in- 
tracellular pH  and MeAIB uptake, showing a steeper slope at 
alkaline  pHs (Fig. 5 ) .  
In spite of the evidence indicating the varying mechanisms 
involved in insulin-  and  vanadate-stimulated system A trans- 
port activity, we found no additive effects of vanadate  and 
insulin stimulating system A. If we bear in mind (a)  that 
vanadate stimulates system A, at least to some extent, by 
changing muscle intracellular  pH,  and ( b )  that insulin acti- 
vates system A transport activity in rat skeletal muscle  by a 
rapid mechanism, independent of protein  synthesis  or  Na+- 
electrochemical gradient and characterized by an increased 
Vmax (14), we favor the view that insulin might enhance the 
intrinsic activity of A carriers  in such a way that  it cannot be 
further activated by vanadate, that is, by a rise in muscle 
intracellular  pH. 
In summary, we have demonstrated that system A in  skel- 
etal muscle can be acutely activated by vanadate  treatment 
and by an increase in muscle intracellular pH. The mecha- 
nisms by which vanadate  stimulates muscle metabolism are 
not a consequence of activation of tyrosine receptor kinase 
activity. However, vanadate causes alkalinization of muscle 
intracellular pH and, in consequence, vanadate effects on 
lactate production and system A transport activity might be 
mediated via modification of intracellular pH. In turn,  the 
mechanism by  which a rise of intracellular pH leads to acti- 
vation of system A transport activity might rely on the pres- 
ence of histidine residues, recently described in A carrier ( 5 ) ,  
possibly localized in a cytosolic domain. 
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